Medtronic (NYSE:MDT) and venture capital firm Sequoia Capital reportedly launched a $60 million fund for medical technology investments in China. The fund aims to back both Chinese startups with the legs for global markets and companies outside China with products that could succeed there, according to the China Money Network. Suzhou-BioBay, a life sciences incubator, also […]
Medtronic
Mauna Kea looks to Medtronic, Stryker, others for help in commercializing Cellvizio
Mauna Kea (ENT:MKEA) founder & CEO Sacha Loiseau is looking to some of the biggest names in medtech for help in commercializing its Cellvizio device in the U.S. after winning 510(k) clearance from the FDA last month. Paris-based Mauna Kea could ink a deal by the end of the year that would allow it to speed Cellvizio to market […]
Medtronic’s Covidien, J&J’s Ethicon bury most of the hatchet in surgical shears spat
Medtronic (NYSE:MDT) subsidiary Covidien and Johnson & Johnson’s (NYSE:JNJ) Ethicon Endo-Surgery unit largely agreed to bury the hatchet in their longtime dispute over patents covering surgical shears. The U.S. Court of Appeals for the Federal Circuit last year overturned a decision awarding $177 million to Covidien, after a Connecticut judge ruled that Ethicon Endo-Surgery’s Harmonic Ace +7 shears infringed surgical shears patents held by Covidien’s […]
Medtronic’s Micra pacer trial meets endpoints
Medtronic‘s (NYSE:MDT) entry into the micro-sized leadless pacemaker market has met its primary safety and effectiveness endpoints with “wide margins,” the company said today. The Micra transcatheter pacing system, which at 1/10th the size of a conventional pacemaker is roughly the size of a large vitamin, is designed to be implanted via catheter in the […]
Medtronic launches VenaSeal varicose vein treatment system in US
Medtronic (NYSE:MDT) said today it launched its VenaSeal closure system for treating varicose veins in the lower extremities. The treatment from the Fridley, Minn.-based medical giant uses a proprietary medical adhesive to close superficial veins in lower extremities in patients with symptomatic venous reflux, or varicose veins. “Patients are often told their varicose veins are only a […]
VIVA 2015 Roundup: Medtronic touts Valiant stent graft, PAD stent-treatment data
Medtronic (NYSE:MDT) this week presented data from 2 studies of its stent systems and announced a new study of its In.Pact Admiral drug-coated balloon. The announcements were made at the VIVA physicians annual conference in Las Vegas, Nev. The Fridley, Minn.-based medical giant presented data from a 2-year clinical trial of its Valiant Captivia thoracic stent graft […]
Medtronic 2015 report: Increased patient benefits, $1.64b invested R&D
Medtronic (NYSE:MDT) today released its 2015 integrated performance report, highlighting higher patient acquisition rates after its Covidien buy and its $1.64 billion investment in research & development. Since its purchase of Covidien, Medtronic said it has expanded the number of patients who use its devices and therapies to 2 per second. “That’s a key reason we acquired […]
Boston Scientific, Edwards facing off in new TAVR battle
Updated: Included information from the Edwards settlement in May. A new patent spat is being fought in Germany by Boston Scientific (NYSE:BSX), which alleges that Edwards Lifesciences (NYSE:EW) is infringing on a patent associated with its Lotus transcatheter heart valve. Late last month, Boston Scientific filed the patent infringement in Dusseldorf alleging that the Edwards Sapien 3 transcatheter aortic valve replacement […]
Medtronic cuts 150 jobs at Dublin care center
Medtronic (NYSE:MDT) is shedding 150 jobs from a customer care center in Dublin, where it recently relocated after its $50 billion merger with Covidien, according to The Irish Times. The jobs being cut are all from Medtronic’s Dublin-based Cherrywood center, which offers customer support to European clients in a variety of languages, according to the paper. The […]
Medtronic touts In.Pact Admiral DCB data
Medtronic (NYSE:MDT) today touted data from a pair of studies of its In.Pact Admiral drug-coated balloon, presented today at the annual Vascular Interventional Advances conference in Las Vegas. Researchers revealed the formal cost-effectiveness analysis of the U.S. cohort of Medtronic’s In.Pact SFA trial, and in-stent restenosis cohort data from its In.Pact Global study. Medtronic said the 2-year, […]
Appeals court rules for Medtronic in remote monitoring patent spat
A federal appeals court yesterday handed a win to Medtronic (NYSE:MDT) that could wind up helping Twin Cities rival St. Jude Medical (NYSE:STJ), in a pair of decisions concerning patents covering remote patient monitoring technology. In the Medtronic case, the U.S. Court of Appeals for the Federal Circuit ruled that a lower court judge wrongly interpreted the patent, […]